Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

2012 Scrip 100: Regeneron eyes a bright future

This article was originally published in Scrip

Executive Summary

Regeneron has shown how a company can leverage itself successfully through R&D partnerships, and become one of the top 10 biotech companies in terms of R&D spend. CEO Dr Len Schleifer talks to Nancy Faigen about the company's profitable partnerships and a rich deal with Sanofi.

Advertisement

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

SC015671

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel